Summary
None of the instrumental met hods used for the detection of Parkinson’s disease, including biochemical tests and imaging techniques, have sufficiently been proved to be more reliable than clinical methods in terms of accuracy and specificity.
Nonetheless, the integration of multiple instrumental methods in field study designs could establish their diagnostic value as early markers in the preclinical stages of Parkinson’s disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bondy B, Dengler FX, Oertel WH, Ackenheil M (1989) 3H-spiperone binding to lymphocytes is increased in schizophrenic patients and decreased in Parkinson patients. In: Przuntek H, Riederer P (eds) Early diagnosis and preventive therapy in Parkinson’s disease. Springer, Wien New York, pp 205–212
El-Awar M, Becker JT, Hammond KM, Nebes RD, Boller F (1987) Learning deficits in Parkinson’s disease. Comparison with Alzheimer’s disease and normal aging. Arch Neurol 44: 180–184
Fitts PM (1954) The information capacity of the human motor system in controlling the amplitude of movement. J Exp Psychol 47: 381–391
Freund H- J, Büdingen HJ (1978) The relationship between speed and amplitude of the fastest voluntary contractions of human arm muscles. Exp Brain Res 31: 1–12
Hefter H, Hömberg V, Lange H, Freund H-J (1987) Impairment of rapid movements in Huntington’s disease. Brain 110: 585–612
Hefter H, Hömberg V, Freund H-J (1989) Quantitative analysis of voluntary and involuntary motor phenomena in Parkinson’s disease. In: Przuntek H, Riederer P (eds) Early diagnosis and preventive therapy in Parkinson’s disease. Springer, Wien New York, pp 65–73
Hömberg V, Hefter H, Reiners K, Freund H-J (1987) Differential effects of changes in mechanical limb properties on physiological and pathological tremor. J Neurol Neurosurg Psychiatry 50: 568–579
Jörg J, Gerhard H (1987) Somatosensory motor and special visual evoked potentials to single and double stimulation in “Parkinson’s disease”—an early diagnostic test? J Neural Transm [Suppl 25]: 81–88
Johnels B, Ingvarsson PE, Rydgren U, Thorselius M, Steg G (1987) Measuring motor function in Parkinson’s disease. In: Marsden CD, Conrad B, Benecke R (eds) Motor disturbances I. Academic Press, London, pp 131–144
Kraus PH, Klotz P, Fischer A, Przuntek H (1987) Assessment of symptoms of Parkinson’s disease by apparative methods. In: Riederer P, Przuntek H (eds) MAO-B inhibitor selegiline (R-(—)-deprenyl), a new therapeutic concept in the treatment of Parkinson’s disease. J Neural Transm [Suppl 25]: 89–96
Leenders KL, Palmer AJ, Quinn N, Clark JC, Firnau G, Garnett ES, Nahmias C, Jones T, Marsden CD (1986) Brain dopamine metabolism in patients with Parkinson’s disease measured with positron emission tomography. J Neurol Neurosurg Psychiatry 49: 853–856
Lees A J, Smith E (1983) Cognitive deficits in the early stages of Parkinson’s disease. Brain 106: 257–270
Lehrl S, Gallwitz A, Blaha L (1980) KAI; Kurztest für allgemeine Intelligenz. VLESS Verlagsgesellschaft mbH, Vaterstetten
Mildworf B, Globus M, Melamed E (1986) Patterns of cognitive impairment in patients with DAT and Parkinson’s disease. Adv Behav Biol 29: 135–140
Poewe W, Gerstenbrand F, Ransmayr G, Plörer S (1983) Premorbid per- sonality of Parkinson patients. J Neural Transm [Suppl 19]: 215–224
Rolf LH, Klauke Th, Fünfgeld EW, Brune GG (1989) Aspartate, glutamate, and glutamine in platelets of patients with Parkinson’s disease. In: Przuntek H, Riederer P (eds) Early diagnosis and preventive therapy in Parkinson’s disease. Springer, Wien New York, pp 221–227
Scholz E, Bacher M, Bellenberg A, Hart S, Diener HC, Dichgans J (1989) Long-term measurement of tremor: early diagnostic possibilities. In: Przuntek H, Riederer P (eds) Early diagnosis and preventive therapy in Parkinson’s disease. Springer, Wien New York, pp 93–102
Schoppe KJ (1974) Das MLS-Gerät: Ein neuer Testapparat zur Messung feinmotorischer Leistungen. Diagnostica 20: 43–46
Steinberg R, Przuntek H (1989) Psychometric assessment of early signs of dementia in special consideration of Parkinson’s and Alzheimer’s disease — an update. In: Przuntek H, Riederer P (eds) Early diagnosis and preventive therapy in Parkinson’s disease. Springer, Wien New York, pp 19–32
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag/Wien
About this chapter
Cite this chapter
Przuntek, H. (1990). Early markers in Parkinson’s disease. In: Dostert, P., Riederer, P., Strolin Benedetti, M., Roncucci, R. (eds) Early Markers in Parkinson’s and Alzheimer’s Diseases. New Vistas in Drug Research, vol 1. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9098-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9098-2_2
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-9100-2
Online ISBN: 978-3-7091-9098-2
eBook Packages: Springer Book Archive